Proton Pump Inhibitor Use Is Not Strongly Associated With SARS-CoV-2 Related Outcomes: A Nationwide Study and Meta-analysis

Autor: Israelsen, Simone Bastrup, Ernst, Martin Thomsen, Lundh, Andreas, Lundbo, Lene Fogt, Sandholdt, Håkon, Hallas, Jesper, Benfield, Thomas

Publikováno v: In Clinical Gastroenterology and Hepatology September 2021 19(9):1845-1854

Acceptable Success Rate in Patients With Periprosthetic Knee Joint Infection Treated With Debridement, Antibiotics, and Implant Retention

Autor: Ottesen, Casper S., Troelsen, Anders, Sandholdt, Håkon, Jacobsen, Steffen, Husted, Henrik, Gromov, Kirill

Publikováno v: In The Journal of Arthroplasty February 2019 34(2):365-368

Predictors of undiagnosed prevalent type 2 diabetes – The Danish General Suburban Population Study

Autor: Heltberg, Andreas, Andersen, John Sahl, Sandholdt, Håkon, Siersma, Volkert, Kragstrup, Jakob, Ellervik, Christina

Publikováno v: In Primary Care Diabetes February 2018 12(1):13-22

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2

Autor: Israelsen, Simone Bastrup, Pottegård, Anton, Sandholdt, Håkon, Madsbad, Sten, Thomsen, Reimar Wernich, Benfield, Thomas

Publikováno v: Israelsen, S B, Pottegård, A, Sandholdt, H, Madsbad, S, Thomsen, R W & Benfield, T 2021, ' Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2 ', Diabetes, Obesity and Metabolism, vol. 23, no. 6, pp. 1397-1401 . https://doi.org/10.1111/dom.14329
Diabetes, Obesity & Metabolism
Diabetes, Obesity and Metabolism

Incretin‐based therapies, glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and dipeptidyl peptidase‐4 inhibitors (DPP‐4i), have been hypothesized to exert beneficial effects on COVID‐19 outcomes due to anti‐inflammatory propertie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::95c9668d80fd94d481cc4473761e949e
https://pure.au.dk/portal/da/publications/comparable-covid19-outcomes-with-current-use-of-glp1-receptor-agonists-dpp4-inhibitors-or-sglt2-inhibitors-among-patients-with-diabetes-who-tested-positive-for-sarscov2(402263cd-ea22-4fd0-afec-5a09c25ed8c5).html